Whole exome sequencing of adenoid cystic carcinoma.

J Clin Invest 2013 Jul 17;123(7):2965-8. Epub 2013 Jun 17.

Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom.

Adenoid cystic carcinoma (ACC) is a rare malignancy that can occur in multiple organ sites and is primarily found in the salivary gland. While the identification of recurrent fusions of the MYB-NFIB genes have begun to shed light on the molecular underpinnings, little else is known about the molecular genetics of this frequently fatal cancer. We have undertaken exome sequencing in a series of 24 ACC to further delineate the genetics of the disease. We identified multiple mutated genes that, combined, implicate chromatin deregulation in half of cases. Further, mutations were identified in known cancer genes, including PIK3CA, ATM, CDKN2A, SF3B1, SUFU, TSC1, and CYLD. Mutations in NOTCH1/2 were identified in 3 cases, and we identify the negative NOTCH signaling regulator, SPEN, as a new cancer gene in ACC with mutations in 5 cases. Finally, the identification of 3 likely activating mutations in the tyrosine kinase receptor FGFR2, analogous to those reported in ovarian and endometrial carcinoma, point to potential therapeutic avenues for a subset of cases.

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI67201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999050PMC
July 2013
64 Reads

Publication Analysis

Top Keywords

adenoid cystic
8
cystic carcinoma
8
exome sequencing
8
chromatin deregulation
4
deregulation half
4
tyrosine kinase
4
cases
4
implicate chromatin
4
combined implicate
4
mutations
4
mutations identified
4
identified cancer
4
cases mutations
4
kinase receptor
4
cancer genes
4
half cases
4
mutated genes
4
acc delineate
4
delineate genetics
4
fgfr2 analogous
4

References

(Supplied by CrossRef)

Rao et al.
Clin Cancer Res. 2008

Similar Publications